VenoStent

Houston, United States

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

$4.0M raised

Jun 2024

Series A

Top Investors

National Science FoundationNorwest Venture PartnersY CombinatorAlumni VenturesGood Growth Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VenoStent raised?

VenoStent has raised $4.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.

Who are VenoStent's investors?

VenoStent's investors include National Science Foundation, Norwest Venture Partners, Y Combinator, Alumni Ventures, Good Growth Capital.

Where is VenoStent headquartered?

VenoStent is headquartered in Houston, United States.

What does VenoStent do?

VenoStent is a tissue engineering medical device company developing bioabsorbable polymer wraps for better outcomes in vascular surgery.

What stage is VenoStent at?

VenoStent is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 27, 2024.

MLA

"VenoStent — Funding & Investors." VCBacked, June 27, 2024, https://www.vcbacked.co/company/venostent. Accessed June 4, 2026.

APA

VCBacked. (2024). VenoStent — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/venostent

Wikipedia (cite web)

{{cite web |title=VenoStent — Funding & Investors |url=https://www.vcbacked.co/company/venostent |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 27, 2024.